EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

AAV9 Gene Therapy for Ovarian Dysfunction and Reproductive Aging: Molecular Mechanisms, Therapeutic Targets, and Translational Perspectives

Safeer Ullah iD, Imran Ullah iD, Beshoy Sameh Fawzy Khalil iD, Zhaojun Geng iD, Jihyo Kim iD, Seung-Eun Lee, Xiaochun Wu, Kamran Saeed, Abdus Saboor Shah, Muhammad Idrees iD, Il-Keun Kong

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198516 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Safeer Ullah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Applied Life Science (BK21 Four), Gyeongsang National University, Jinju 52828, Gyeongnam Province, Republic of Korea. Hauptthemen laut MEDLINE: Genetic Therapy, Dependovirus, Aging, Ovary. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education (MOE) and the Gyeongsangnam-do Provincial Government, Republic of Korea, Thekingkong Corp. Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Female infertility is a growing concern in developed countries as delayed childbearing and ovarian dysfunction become more common. Ovarian decline is characterized by follicular depletion, granulosa cell dysfunction, aneuploidy, spindle assembly defects, mitochondrial damage, DNA damage, telomere shortening, stromal remodeling, and cellular senescence. Current approaches (hormonal therapy, assisted reproductive technologies, platelet-rich plasma, stem cells, extracellular vesicles, and mitochondrial-targeted treatments) offer partial benefit but do not directly correct the molecular drivers of ovarian dysfunction. Gene therapy via viral vectors offers a more direct strategy. Adeno-associated virus serotype 9 (AAV9) is attractive for its broad tropism, long-term transgene expression, favorable safety profile, and evidence of ovarian somatic cell transduction, particularly in granulosa and interstitial cells. It remains experimental, however, and requires rigorous evaluation of biodistribution, immune response, off-target effects, germline safety, embryo development, offspring health, and tumorigenic risk. This review summarizes the mechanisms of ovarian dysfunction, current therapeutic limitations, AAV9’s advantages, delivery routes, candidate genes, and translational safety concerns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyDependovirusAgingOvaryInfertility, FemaleOvarian DiseasesHumansFemaleAnimalsGene Therapy AgentsGenetic VectorsReproduction

Stichwörter der Autor:innen

AAV9female infertilitygene therapyovarian dysfunctionreproductive aging

Autor:innen und Institutionen

  • Division of Applied Life Science (BK21 Four), Gyeongsang National University, Jinju 52828, Gyeongnam Province, Republic of Korea.
  • Institute of Agriculture and Life Science, Gyeongsang National University, Jinju 52822, Gyeongnam Province, Republic of Korea.
  • Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Islamabad Capital Territory, Pakistan.
  • Biochemistry Research Laboratory, Department of Chemistry, GPGC Bannu, University of Science and Technology, Bannu 28100, Khyber-Pakhtunkhwa, Pakistan.
  • The King Kong Co., Ltd., Gyeongsang National University, Jinju 52828, Gyeongnam Province, Republic of Korea.
  • Division of Animal Science, Gyeongsang National University, Jinju 52828, Gyeongnam Province, Republic of Korea.

ORCID-Profile: Safeer Ullah, Imran Ullah, Beshoy Sameh Fawzy Khalil, Zhaojun Geng, Jihyo Kim, Muhammad Idrees

Förderung

  • National Research Foundation of Korea
  • Ministry of Education (MOE) and the Gyeongsangnam-do Provincial Government, Republic of Korea
  • Thekingkong Corp. Ltd.
  • scholarship from the BK21 Four program

Zitieren

APA

Ullah, S., Ullah, I., Khalil, B. S. F., Geng, Z., Kim, J., Lee, S. E., Wu, X., Saeed, K., Shah, A. S., Idrees, M., & Kong, I. K. (2026). AAV9 Gene Therapy for Ovarian Dysfunction and Reproductive Aging: Molecular Mechanisms, Therapeutic Targets, and Translational Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198516

Vancouver

Ullah S, Ullah I, Khalil BSF, Geng Z, Kim J, Lee SE, et al. AAV9 Gene Therapy for Ovarian Dysfunction and Reproductive Aging: Molecular Mechanisms, Therapeutic Targets, and Translational Perspectives. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198516

BibTeX
@article{Ullah2026,
  author = {Ullah, Safeer and Ullah, Imran and Khalil, Beshoy Sameh Fawzy and Geng, Zhaojun and Kim, Jihyo and Lee, Seung-Eun and Wu, Xiaochun and Saeed, Kamran and Shah, Abdus Saboor and Idrees, Muhammad and Kong, Il-Keun},
  title = {AAV9 Gene Therapy for Ovarian Dysfunction and Reproductive Aging: Molecular Mechanisms, Therapeutic Targets, and Translational Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198516}
}
Kostenlos starten →